MedTrace Logo

Stem Cell Therapy in Spinal Cord Injury

NCT02009124 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2018-10-25

No results posted yet for this study

Summary

The purpose of this study is to study the effect of stem cell therapy on common symptoms in patients with spinal cord injury.

Conditions

  • Spinal Cord Injury

Interventions

BIOLOGICAL

Autologous bone marrow mononuclear cell transplantation

Bone marrow is aspirated by a standard procedure. Mononuclear cells are separated by density gradient method and then injected intrathecally by a standard lumbar puncture procedure

Sponsors & Collaborators

  • Neurogen Brain and Spine Institute

    lead OTHER

Principal Investigators

  • Alok K Sharma, MS,MCh · Neurogen Brain and Spine Institute

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
12 Months
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2018-06-30
Completion
2018-12-31

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02009124 on ClinicalTrials.gov